Back

Atrial fibrillation high power radiofrequency ablation: efficiency and safety

28 August 2023 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Catheter ablation and hybrid ablation for atrial fibrillation Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Joao Grade Santos

ULS Almada Seixal - Hospital Garcia de Orta, Almada (Portugal)

4 More presentations in this session

Presentation thumbnail
Early pulmonary vein isolation in patients with heart failure
Doctor P. Toth (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Clinical efficacy of catheter ablation versus medical rate control among patients with atrial fibrillation across heart failure phenotypes: a meta-analysis of randomized controlled trials
Doctor D. Dakay (Binan City, PH)
Abstract Slides Video
Presentation thumbnail
High-density, high-resolution mapping in patients with recurrent atrial fibrillation after cryoballoon pulmonary vein isolation: findings and outcome after repeat ablation
Doctor D. Musat (Paramus, US)
Abstract Slides Video
Presentation thumbnail
Hybrid convergent ablation: an evaluation of left atrial electroanatomical voltage maps
Doctor N. Mannakkara (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation and hybrid ablation for atrial fibrillation

The Event

Event poster

ESC Congress 2023

28 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Biophysical parameters of pulmonary vein isolation with very high-power short-duration compared to conventional radiofrequency ablation guided by ablation index
thumbnail
Congress Presentation
Procedural and clinical outcomes of very high-power short-duration versus ablation index-guided pulmonary vein isolation -The Q-POWER Study -
thumbnail
Congress Presentation
High power short duration and very high power short duration protocol: a comparison between two effective strategies of atrial fibrillation transcatheter ablation with radiofrequency

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources